Short communication · 17 May 2019
ArticlePublished 12 Jun 2024
Testosterone replacement in middleaged men a review
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Testosterone deficiency encompasses clinically low serum testosterone levels accompanied by signs and symptoms. This testosterone decline is expected in older men and begins in middle age (40 to 64 years) and is commonly treated through Testosterone Replacement Therapy (TRT). This review aims to look at the mechanisms of TRT, physiological and societal motivations to seek TRT, ethical and medical considerations behind its use, and future research directions. From the review of numerous papers looking at testosterone therapy in middle-aged men, various mechanisms for the delivery of testosterone were isolated, each with sufficient risks and benefits. Of all the mechanisms looked at, buccal testosterone and implants had more benefits than others in patient adherence and normal circadian variations in serum testosterone, unlike Intramuscular testosterone. Both physiological and societal changes in middle-aged men cause them to seek therapy. Some of these physiological changes include sarcopenia, reduction in bone mineral density, depressive mood symptoms, reduced libido, and erectile dysfunction. Societal changes, which also influence treatment-seeking, include feelings of “lost masculinity” associated with loss of strength and virility with old age. This societal pressure can lead to a desire to maintain youthful vigor, a significant motivator for seeking TRT. Due to substantial societal and media changes, TRT use in the United States has tripled between 2001 and 2011, raising concerns that many individuals may be receiving treatment without being appropriately informed on the risks and benefits and without clear clinical indications. Although extensive research is available in this field, there remain unanswered questions regarding the effects on non-communicable diseases like cardiovascular disease and cancers. While prostate cancer, in particular, is not related to TRT use, further research is needed to prove the relationship. Additionally, there is untapped potential for TRT beyond the scope of hypogonadism, but researchers have yet to explore these areas of benefit.
Keywords
Subjects
Dentistry & Oral HealthAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2 Mar 2018
The Effect of Testosterone Replacement Therapy on Glycemic Control in Hypogonadal Men with Type 2 Diabetes Mellitus
Research article · 15 Apr 2017
Effects of testosterone replacement therapy on glucose and lipid metabolism in middle-aged and elderly high-fat-fed male rats
Short communication · 28 Feb 2022
Influence of testosterone replacement therapy on metabolic disorders and autonomic diabetic neuropathy in patient with type 2 diabetes mellitus and Androgen deficiency
Conference abstract · 16 Jul 2019
Influence of testosterone replacement therapy on metabolic disorders and autonomic diabetic neuropathy in patient with type 2 diabetes mellitus and Androgen deficiency
More from this journal
The newest in Journal of Research in Medical and Dental Science.
Article · 26 Aug 2026
Fullmouth dental rehabilitation under general anesthesia in an 8yearold male with dandywalker syndrome a case report
Article · 29 May 2026
Unaltered frictional force between graphene oxidecoated stainless steel wires and orthodontic bracket in acidic ph
Article · 11 Feb 2026
Intravenous Regional Anaesthesia Using Lidocaine and Magnesium-Randomized, Controlled, Double-Blinded Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Research in Medical and Dental Science
- SubjectDentistry & Oral Health
- BylineArticles whose byline prints “Meribole Somtochukwu Emmanuel”
